Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesLNA Sante SA

LNA Sante SA

PortfolioPortfolio WatchlistWatchlist
Company price
23.8 GBX 0.10 ( 0.42%)
Last update at 2026-10-27T14:40:00Z
VOLUME
175
Market Cap
273.38M
P/E
0.12

Momentum Score

…

LNA Santé SA engages in the management and operation of healthcare facilities and medical residences for able-bodied, semi-dependent, or dependent elderly people in France. The company operates medical care and rehabilitation units; mental health clinics; health centres; and care homes. It also provides respiratory assistance and rehabilitation, cancerology, diabetology, pain management, therapeutic education for the patient and his/her family, geriatrics, enteral and parenteral nutrition, obstetrics, antenatal and postnatal, complex dressings and specific care, post-operative care, anti-cancer chemotherapy, post-chemotherapy, radiotherapy and aplasia monitoring, psychological or social care, neurological and orthopedic rehabilitation, palliative care, intensive nursing care, intravenous treatment/infusion, blood transfusion, education for the patient and his/her loved ones, paracentesis, pleural or peritoneal drainage, and other treatment services. In addition, the company offers general, ENT carcinological, digestive and urology, dental, spinal, cosmetic, gynecological and obstetric, maxillo-facial, eye, ENT, orthopedic and trauma, plastic and cosmetic facial, stomatological, urological, vascular, and visceral and digestive surgery, as well as digestive endoscopies and hepato-gastroenterology services. LNA Santé SA was founded in 1990 and is based in Vertou, France.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
23.60
Low
23.80
High
52 Week Price Range
21.93
Low
32.70
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
23.70
Dividend Yield
3.05%
Revenue TTM
912.67M
Revenue Per Share
84.30
Gross Profit TTM
68.74M
Debt / Equity
2.75
ROE
6.87%
Net Debt
812.42M
ROCE
6.61%
Diluted EPS TTM
2.45

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 39.77M 34.12M 37.32M 44.25M 38.57M
Net income 24.14M 21.82M 23.41M 25.81M 23.51M
Selling general administrative - 98.11M 90.21M - -
Selling and marketing expenses - - 89.86M - -
Gross profit 102.28M 91.10M 241.09M 242.43M 229.46M
Ebit 75.33M 63.11M 64.23M 57.24M 58.78M
Ebitda 160.59M 144.85M 144.63M 84.35M 83.78M
Depreciation and amortization 85.26M 81.74M 80.41M 27.11M 25.00M
Operating income 75.33M 68.97M 62.98M 57.24M 58.78M
Other operating expenses 837.34M 744.20M 673.10M 663.12M 631.12M
Interest expense 29.51M 29.00M 27.27M - 0.00M
Income tax expense 14.06M 11.02M 13.02M 15.91M 14.59M
Total revenue 912.67M 806.60M 736.09M 728.22M 689.49M
Total operating expenses 26.95M 193.37M 178.11M 177.32M 171.09M
Cost of revenue 810.39M 715.51M 495.00M 485.80M 460.04M
Total other income expense net -35.56M - -25.66M -12.99M -20.21M
Net income applicable to common shares - - - 25.81M 23.51M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1599.92M 1538.19M 1507.13M 1513.10M 1529.79M
Intangible assets - 441.08M 422.64M 423.26M 410.53M
Other current assets 44.48M 41.82M 52.16M 48.82M 50.59M
Total liab 1258.42M 1214.63M 1198.62M 1214.31M 1306.80M
Total stockholder equity 330.25M 313.81M 299.24M 289.33M 216.09M
Other current liab 157.86M 95.75M 141.11M 433.27M 486.60M
Common stock 21.42M 21.42M 21.42M 21.42M 19.51M
Retained earnings 209.24M 192.80M 23.41M 25.81M 23.51M
Other liab - - - 101.71M 96.17M
Good will - 137.42M 139.31M 139.60M 136.13M
Other assets - - - 9.82M 6.68M
Cash 94.83M 75.06M 77.17M 101.98M 151.77M
Total current liabilities 460.87M 412.32M 353.97M 496.49M 549.02M
Current deferred revenue - - 3.00M - -
Net debt 812.42M 861.45M 810.50M -101.98M -151.77M
Short term debt 222.88M 240.06M 144.92M - -
Short long term debt total 907.25M 936.51M 887.67M - -
Other stockholder equity 99.59M 84.89M 84.99M 242.10M 173.07M
Property plant equipment - - - 609.70M 616.71M
Total current assets 421.38M 374.14M 333.74M 318.73M 354.49M
Net tangible assets - - - -273.53M -330.57M
Net receivables 84.39M 78.26M 56.12M 69.53M 66.48M
Inventory 197.69M 179.01M 148.30M 98.41M 85.66M
Accounts payable 80.12M 76.52M 64.94M 63.22M 62.42M
Accumulated other comprehensive income - 185.68M 169.42M - -
Non currrent assets other - - 422.64M -1184.55M -1168.62M
Non current assets total 1178.54M 1164.06M 1173.39M 1184.55M 1168.62M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - - 0.07M 2.06M
Change to liabilities - - - 0.00M 0.00M
Total cashflows from investing activities -14.21M -23.72M -15.69M -41.99M -27.65M
Net borrowings - - - -130.26M -1.31M
Total cash from financing activities -36.50M -88.80M -106.69M -110.88M -21.53M
Change to operating activities - - - - -28.84M
Net income 24.14M 21.82M 23.41M 25.81M 23.51M
Change in cash 19.77M -2.12M -24.87M -49.66M 30.75M
Begin period cash flow 75.06M 77.17M 101.97M 151.63M 120.89M
End period cash flow 94.83M 75.06M 77.10M 101.97M 151.63M
Total cash from operating activities 70.42M 110.44M 97.50M 103.20M 79.92M
Depreciation 85.26M 81.74M 80.41M 84.47M 81.18M
Other cashflows from investing activities - 2.03M -0.99M 0.19M -0.24M
Dividends paid 6.67M 6.14M 5.11M 4.52M 1.92M
Change to inventory -41.05M -33.99M -52.05M -19.76M 1.41M
Change to account receivables -8.50M -14.40M 12.14M -0.66M -16.00M
Sale purchase of stock - - -6.52M -4.44M -0.52M
Other cashflows from financing activities -60.24M -88.79M -84.79M 180.85M 279.17M
Change to netincome - - - - 18.34M
Capital expenditures 11.13M 10.82M 12.95M 11.96M 10.24M
Change in working capital -46.45M -23.76M -38.85M -20.42M -14.60M
Stock based compensation - - 0.51M -0.04M 0.21M
Other non cash items 7.47M 30.64M 32.03M 13.38M -10.38M
Free cash flow 59.30M 71.24M 84.56M 91.24M 69.68M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0OR2
LNA Sante SA		 0.10
0.42%		 23.80 0.12 - 0.30 -
0R15
SoftBank Group Corp.		 248.00
5.84%		 4494.00 - - - -
0R1E
Nintendo Co. Ltd.		 -115.00
1.34%		 8476.00 - - - -
0LC3
Synchrony Financial		 2.34
3.20%		 75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A		 0.15
0.12%		 122.47 0.25 - 1.18 -

Profile*

LNA Sante SA

LNA Santé SA engages in the management and operation of healthcare facilities and medical residences for able-bodied, semi-dependent, or dependent elderly people in France. The company operates medical care and rehabilitation units; mental health clinics; health centres; and care homes. It also provides respiratory assistance and rehabilitation, cancerology, diabetology, pain management, therapeutic education for the patient and his/her family, geriatrics, enteral and parenteral nutrition, obstetrics, antenatal and postnatal, complex dressings and specific care, post-operative care, anti-cancer chemotherapy, post-chemotherapy, radiotherapy and aplasia monitoring, psychological or social care, neurological and orthopedic rehabilitation, palliative care, intensive nursing care, intravenous treatment/infusion, blood transfusion, education for the patient and his/her loved ones, paracentesis, pleural or peritoneal drainage, and other treatment services. In addition, the company offers general, ENT carcinological, digestive and urology, dental, spinal, cosmetic, gynecological and obstetric, maxillo-facial, eye, ENT, orthopedic and trauma, plastic and cosmetic facial, stomatological, urological, vascular, and visceral and digestive surgery, as well as digestive endoscopies and hepato-gastroenterology services. LNA Santé SA was founded in 1990 and is based in Vertou, France.

7 boulevard Auguste Prioué, Vertou, France, 44120

33 2 40 16 01 61

https://www.lna-sante.com

8282

Name Title Year Born
Mr. Jean Paul Siret Founder, Chairman & CEO 1952
Mr. Damien Billard Deputy CEO of Fin. & Director 1974
Mr. Willy Siret Deputy Chief Exec. Officer of Operations & Director 1974
Mr. Jean Paul Siret Founder & Chairman 1951
Mr. Willy Siret MD & Director 1974
Mr. Damien Billard Deputy MD of Finance, CFO & Director 1973

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…